85796336 - SOLUFERON

Information

  • Trademark
  • 85796336
  • Serial Number
    85796336
  • Filing Date
    December 06, 2012
    12 years ago
  • Transaction Date
    July 18, 2017
    7 years ago
  • Status Date
    July 17, 2017
    7 years ago
  • Published for Opposition Date
    April 15, 2014
    10 years ago
  • Location Date
    June 08, 2015
    9 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    BENJAMIN, SARA NICOLE
  • Attorney Docket Number
    12790001MA
    Attorney Name
    Robert N. Cook
    Law Office Assigned Location Code
    M10
  • Owners
Mark Drawing Code
4000
Mark Identification
SOLUFERON
Case File Statements
  • GS0011: Chemical preparations for scientific and medical research purposes; protein for use in scientific and medical research; cultures of microorganisms and preparations derived therefrom for scientific and medical research purposes, namely, interferons and interferon-beta derivatives; cultures of microorganisms and preparations derived therefrom for laboratories, namely, interferons and interferon-beta derivatives; protein in a raw material form for scientific and medical research
  • GS0051: Pharmaceutical and veterinary preparations, namely, immunomodulators; pharmaceutical and veterinary preparations, namely, interferon and interferon-beta derivatives for the treatment of infectious diseases or neurological disorders; pharmaceutical and veterinary products, namely, immunomodulators; pharmaceutical and veterinary products, namely, interferons and interferon-beta derivatives for treating diseases, namely, hepatitis infection, chronic obstructive pulmonary syndrome (COPD) and multiple sclerosis; cultures of microorganisms and preparations derived therefrom for medical or veterinary purposes, namely, interferons and interferon-beta derivatives for the treatment of infectious diseases and neurological disorders
  • GS0401: Custom manufacture of pharmaceutical preparations; manufacture of pharmaceutical preparations to order; manufacture of pharmaceutical preparations for others; custom manufacture of immunomodulators; manufacture of immunomodulators to order; manufacture of immunomodulators for others
  • GS0421: Scientific and technological services, namely, scientific and technological services related to interferons and interferon-beta derivatives in the nature of product development and research relating thereto, namely, pharmaceutical research in the areas of virology, immunology, neurology, or pulmonology; services of chemists; services of biologists, biochemists or biotechnologists, namely, scientific research, pharmaceutical research, or product development; drawing up expert opinions relating to subjects from natural science or medicine, namely, scientific research, pharmaceutical research, or product development; scientific and technical project evaluations, namely, scientific product evaluations in the nature of product testing, pharmaceutical product evaluations, or product development evaluations in the nature of product testing; technical project management for research and development projects in the field of natural sciences or medicine; medical and scientific research, namely, conducting clinical and scientific studies; industrial chemical characterization, namely, chemical, physicochemical, physical and biological analysis, industrial research services in the field of pharmaceuticals; development of new technology and products for others on the basis of research results in the field of natural sciences and medicine
  • GS0441: Medical services; veterinary sevices; pharmacists services to make up prescriptions; physician services; treatment of medical conditions; treatment of medical conditions using immunomodulators; treatment of medical conditions using interferon; medical diagnostic testing, monitoring and reporting services; providing medical information about viral disease, cancer diseases, diseases responsive to immunomodulators and diseases responsive to interferons
  • GS0451: Exploitation of rights to results of research and pharmaceutical products, namely, patent licensing; licensing of intellectual property
Case File Event Statements
  • 7/17/2017 - 7 years ago
    53 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Type: MAB6
  • 7/17/2017 - 7 years ago
    52 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 12/1/2016 - 8 years ago
    51 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/30/2016 - 8 years ago
    50 - EXTENSION 5 GRANTED Type: EX5G
  • 11/14/2016 - 8 years ago
    49 - EXTENSION 5 FILED Type: EXT5
  • 11/14/2016 - 8 years ago
    48 - TEAS EXTENSION RECEIVED Type: EEXT
  • 6/25/2016 - 8 years ago
    47 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/24/2016 - 8 years ago
    46 - EXTENSION 4 GRANTED Type: EX4G
  • 5/17/2016 - 8 years ago
    45 - EXTENSION 4 FILED Type: EXT4
  • 6/24/2016 - 8 years ago
    44 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 5/17/2016 - 8 years ago
    43 - TEAS EXTENSION RECEIVED Type: EEXT
  • 12/11/2015 - 9 years ago
    42 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/10/2015 - 9 years ago
    41 - EXTENSION 3 GRANTED Type: EX3G
  • 11/12/2015 - 9 years ago
    40 - EXTENSION 3 FILED Type: EXT3
  • 12/9/2015 - 9 years ago
    39 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 11/12/2015 - 9 years ago
    38 - TEAS EXTENSION RECEIVED Type: EEXT
  • 6/9/2015 - 9 years ago
    37 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/8/2015 - 9 years ago
    36 - EXTENSION 2 GRANTED Type: EX2G
  • 5/8/2015 - 9 years ago
    35 - EXTENSION 2 FILED Type: EXT2
  • 6/8/2015 - 9 years ago
    34 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 5/8/2015 - 9 years ago
    33 - TEAS EXTENSION RECEIVED Type: EEXT
  • 10/30/2014 - 10 years ago
    32 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/28/2014 - 10 years ago
    31 - EXTENSION 1 GRANTED Type: EX1G
  • 10/28/2014 - 10 years ago
    30 - EXTENSION 1 FILED Type: EXT1
  • 10/28/2014 - 10 years ago
    29 - TEAS EXTENSION RECEIVED Type: EEXT
  • 10/28/2014 - 10 years ago
    28 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 6/10/2014 - 10 years ago
    27 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 4/15/2014 - 10 years ago
    26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/15/2014 - 10 years ago
    25 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/26/2014 - 10 years ago
    24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/7/2014 - 10 years ago
    23 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 3/7/2014 - 10 years ago
    22 - ASSIGNED TO LIE Type: ALIE
  • 2/19/2014 - 10 years ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/19/2014 - 10 years ago
    20 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/19/2014 - 10 years ago
    19 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/19/2014 - 10 years ago
    18 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 2/19/2014 - 10 years ago
    17 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 2/5/2014 - 10 years ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/5/2014 - 10 years ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/5/2014 - 10 years ago
    14 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 8/11/2013 - 11 years ago
    13 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 8/11/2013 - 11 years ago
    12 - FINAL REFUSAL E-MAILED Type: GNFR
  • 8/11/2013 - 11 years ago
    11 - FINAL REFUSAL WRITTEN Type: CNFR
  • 7/23/2013 - 11 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/22/2013 - 11 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/22/2013 - 11 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/22/2013 - 11 years ago
    7 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/25/2013 - 11 years ago
    6 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 3/25/2013 - 11 years ago
    5 - PRIORITY ACTION E-MAILED Type: GPRA
  • 3/25/2013 - 11 years ago
    4 - PRIORITY ACTION WRITTEN Type: CPRA
  • 3/25/2013 - 11 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/17/2012 - 12 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 12/10/2012 - 12 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP